Abstract:Objective To explore the role of ferroptosis in LPS-induced sepsis associated acute kidney injury(S-AKI via in vivo and in vitro models. Methods A mouse model of sepsis was established and randomly divided into 4 groups: the control group, lipopolysaccharide（LPS） group, LPS+Ferrostatin-1（Fer-1） group and LPS+Deferoxamine（DFO） group, 3 mice for each group. Mice in LPS group were administered intraperitoneally with LPS at a dose of 15 mg/kg, and those in ferroptosis inhibitor group were intraperitoneally injected with Fer-1（5 mg/kg） or DFO（100 mg/kg） 30 minutes before LPS injection, respectively. Blood and kidney samples were collected 24 hours later for renal function and ferroptosis markers detection. Human renal tubular epithelial cells（HK-2） were exposed to 100 μg/mL LPS stimulation for 24 h, and cell viability, labile iron pool（LIP） and lipid peroxidation were detected. After transfection to HK-2 cells with siRNA against ferroportin（FPN）, the expression of ferroptosis markers were detected. Results Compared with the control group, the levels of serum creatinine and urea nitrogen of mice in LPS group were significantly higher, the renal pathological injury was aggravated, and ferroptosis markers were remarkably increased. However,ferroptosis inhibitors could significantly relieve the kidney functional and pathological injury induced by LPS, and reduce the expression of ferroptosis markers. Meanwhile, FPN expression was significantly down-regulated in LPS-induced S-AKI group both in vivo and in vitro, and obvious ferroptosis markers were observed in HK-2 cells silenced by siRNA for FPN, suggesting that FPN was involved in ferroptotic injury. qRT-PCR results showed that down-regulation of FPN was associated with increased hepcidin in the kidney. Further tests showed that LPS activated the hepcidin promoter IL-6/STAT3 pathway, while Fer-1 and DFO inhibited the activation of related pathway, reduced hepcidin mRNA expression, and prevented the down-regulation of FPN. Conclusions LPS can induce down-regulation of FPN mediated ferroptosis, and ferroptosis inhibitors may play a protective role in LPS-induced S-AKI through inhibiting the degradation of FPN by hepcidin.

PRDM16 suppresses ferroptosis to protect against sepsis-associated acute kidney injury by targeting the NRF2/GPX4 axis

Overexpression of PRDM16 attenuates acute kidney injury progression: genetic and pharmacological approaches

GPR116 Promotes Ferroptosis in Sepsis-Induced Liver Injury by Suppressing System Xc–/GSH/GPX4

Ginsenoside Rg1 Suppresses Ferroptosis of Renal Tubular Epithelial Cells in Sepsis-induced Acute Kidney Injury via the FSP1-CoQ10-NAD(P)H Pathway

Inhibition of the NADPH Oxidase Pathway Reduces Ferroptosis during Septic Renal Injury in Diabetic Mice

Dexmedetomidine inhibits ferroptosis and attenuates sepsis-induced acute kidney injury via activating the Nrf2/SLC7A11/FSP1/CoQ10 pathway

Andrographolide attenuates sepsis-induced acute kidney injury by inhibiting ferroptosis through the Nrf2/FSP1 pathway

Maresin conjugates in tissue regeneration-1 suppresses ferroptosis in septic acute kidney injury

The Protein Kinase R Inhibitor C16 Alleviates Sepsis-Induced Acute Kidney Injury Through Modulation of the NF-B and NLR Family Pyrin Domain-Containing 3 (NLPR3) Pyroptosis Signal Pathways

The Protein Kinase R Inhibitor C16 Alleviates Sepsis-Induced Acute Kidney Injury Through Modulation of the NF-κB and NLR Family Pyrin Domain-Containing 3 (NLPR3) Pyroptosis Signal Pathways

Mitochondria-derived reactive oxygen species are involved in renal cell ferroptosis during lipopolysaccharide-induced acute kidney injury

MYOCD and SRF-mediated MLCK transcription prevents polymorphonuclear neutrophils from ferroptosis in sepsis-related acute lung injury

Post-treatment With Irisin Attenuates Acute Kidney Injury in Sepsis Mice Through Anti-Ferroptosis via the SIRT1/Nrf2 Pathway

Activation of lipophagy is required for RAB7 to regulate ferroptosis in sepsis-induced acute kidney injury

Attenuation of Sepsis-Induced Acute Kidney Injury by Exogenous H2S via Inhibition of Ferroptosis

Ferroptosis inhibitors attenuate sepsis associated acute kidney injury by protecting ferroportin

CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury

Dexmedetomidine attenuates ferroptosis by Keap1-Nrf2/HO-1 pathway in LPS-induced acute kidney injury

Ginsenoside Rg1 ameliorates sepsis‐induced acute kidney injury by inhibiting ferroptosis in renal tubular epithelial cells

SRS 16-86 promotes diabetic nephropathy recovery by regulating ferroptosis

Selenium binding protein 1 protects renal tubular epithelial cells from ferroptosis by upregulating glutathione peroxidase 4